$146.43
Value $200B
PEP and PETS stock compared: price, dividend, valuation and results, from SEC filings.
$146.43
Value $200B
$0.90
Value $19M
PepsiCo (PEP) has a market value of $200B and PetMed Express (PETS) $19M. Over the last year, with dividends, PEP moved +4.5% and PETS -55.1%. Dividend yield: PEP 3.97%, PETS none.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
PEP$200B
PETS$19M
PEP is 10,421 times PETS
Revenue, 12 months
PEP$98.2B
PETS$160M
PEP is 613 times PETS
Net income, 12 months
PEP$10.9B
PETS-$27M
Operating margin
PEP15.3%
PETS-18.0%
33.3 points apart
ROIC
PEP16.6%
PETS-78.7%
95.3 points apart
P/E
PEP18.4
PETS–
Dividend yield
PEP4.0%
PETS0.0%
4.0 points apart
5-year return
PEP+5.1%
PETS-96.6%
101.7 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
PEP+5.1%
PETS-96.6%
| Period | PEPWith dividends | PETSWith dividends |
|---|---|---|
| 1 year since November 14, 2025 | +4.5%Price +0.4% | -55.1%Price -55.1% |
| 3 years since November 16, 2023 | -2.7%-0.9% a yearPrice -12.7% | -88.2%-50.9% a yearPrice -88.2% |
| 5 years since November 15, 2021 | +5.1%+1.0% a yearPrice -10.6% | -96.6%-49.1% a yearPrice -97.0% |
| 10 years since November 16, 2016 | +96.2%+7.0% a yearPrice +44.0% | -94.4%-25.1% a yearPrice -95.9% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
PEPPepsiCoPETSPetMed Express
| Price | $146.43 | $0.90 |
|---|---|---|
| Market value | $200B | $19M |
| Enterprise value (EV) | $241B | $7.8M |
| P/E | 18.4 | – |
| P/E, 5-year median | 25.9 | – |
| P/B | 9.0 | 1.1 |
| EV/EBIT | 16.0 | – |
| Free cash flow yield | 5.2% | – |
| Revenue, 12 months | $98.2B | $160M |
|---|---|---|
| Net income, 12 months | $10.9B | -$27M |
| Free cash flow, 12 months | $10.5B | -$25M |
| Earnings per share, 12 months | $7.96 | -$1.28 |
| Revenue growth, year on year | 2.3% | -21.1% |
| Revenue growth a year, past | +5.9%over 5 years | -10.0%over 5 years |
| EPS growth a year, past | +3.2%over 5 years | – |
| Gross margin | 54.2% | 27.8% |
|---|---|---|
| Operating margin | 15.3% | -18.0% |
| Net margin | 11.1% | -17.0% |
| ROIC | 16.6% | -78.7% |
| ROE | 51.6% | -94.0% |
| Cash | $11.2B | $11M |
|---|---|---|
| Total debt | $51.9B | $291.0K |
| Net debt / EBITDA | 2.2 | – |
| Interest cover | 13.6× | – |
| Dividend yield | 4.0% | – |
|---|---|---|
| Dividend per share, 12 months | $5.81 | – |
| Dividend growth a year, past | +6.9%over 5 years | – |
| Buyback yield | 0.5% | – |
| Shareholder yield | 4.5% | – |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, PepsiCo ($200B) is about 10,420.9 times PetMed Express ($19M), at today's prices.
Since November 16, 2016, PEP's price moved +44.0% and PETS's -95.9%. With dividends: PEP +96.2% (+7.0% a year), PETS -94.4% (-25.1% a year). Past returns do not predict future ones.
The dividend yield at today's price is 3.97% for PepsiCo and none for PetMed Express. Over the last twelve months they paid $5.81 and – per share.
Over the last twelve months, the net margin was 11.1% for PepsiCo and -17.0% for PetMed Express, and the operating margin 15.3% and -18.0%. Revenue was $98.2B and $160M.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.